Keywords: GlaxoSmithKline, Human Genome Sciences, Benlysta, Lupus, USA, FDA

GlaxoSmithKline/HGS lupus drug Benlysta cleared by US FDA

Article | 10 March 2011

Print This

After an agency delay following an advisory panel backing last November, the US Food and Drug Administration yesterday finally approved ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in